How is the AbCellera Biologics Inc today?

The AbCellera Biologics Inc today is trading in the down by -2.07% at 2.37.

How has AbCellera Biologics Inc performed historically?

The AbCellera Biologics Inc is currently trading down -2.07% on an intraday basis in the past week the index rose 16.18%. The index has been up 1.28% in the past quarter and fell -37.30% in the past year. You can view this in the overview section.

What is AbCellera Biologics Inc Annual Revenue?

AbCellera Biologics Inc Annual Revenue fell 24.17%, in the last year to $28.83 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is AbCellera Biologics Inc Annual Net Profit?

AbCellera Biologics Inc Annual Net Profit fell 11.24% in the last year to $162.86 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is AbCellera Biologics Inc Price to Earning Ratio?

AbCellera Biologics Inc Price to Earning Ratio is -4.21, which is negative.

What is AbCellera Biologics Inc Stock Price?

AbCellera Biologics Inc Stock Price fell 37.3% and underperformed its sector by 65.27% in the past year.

What is AbCellera Biologics Inc Quarterly Revenue?

AbCellera Biologics Inc Quarterly Revenue fell 57.45% YoY to $4.24 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is AbCellera Biologics Inc Quarterly Net profit?

AbCellera Biologics Inc Quarterly Net profit fell 12.34% YoY to $45.62 M. Its sector's average net profit growth YoY for the quarter was -239.15%.

What is AbCellera Biologics Inc Debt to Equity Ratio?

AbCellera Biologics Inc Debt to Equity Ratio of 0.06 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is AbCellera Biologics Inc Return on Equity(ROE)?

AbCellera Biologics Inc Return on Equity(ROE) for the last financial year was -14.75%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is AbCellera Biologics Inc Mutual Fund Holding?

AbCellera Biologics Inc Mutual Fund Holding increased by 1.46% in the last quarter to 16.97.

What is AbCellera Biologics Inc Institutional Holding?

AbCellera Biologics Inc Institutional Holding increased by 3.15% in the last quarter to 43.4.

AbCellera Biologics Inc XNAS: ABCL

AbCellera Biologics Inc Live Share Price Today, Share Analysis and Chart

Name: AbCellera Biologics Inc: Is Infosys Ltd. worth buying?
Item: AbCellera Biologics Inc
Rating: 1.58691675
Author: Trendlyne DVM scores

about

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and...

2.37 -0.05 (-2.07%)

38.92% Fall from 52W High

4.1M XNAS Volume

XNAS 05 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for AbCellera Biologics Inc is on 13 Jun 2025 for the purpose of AbCellera Biologics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

16.7 / 100

Technically Neutral

46.8 / 100

1Yr Price target upside is 256%

7 analysts

AbCellera Biologics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

AbCellera Biologics Inc Live Share Price Today, Share Analysis and Chart

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and...

38.92% Fall from 52W High

SWOT Analysis

AbCellera Biologics Inc Live Price Chart

AbCellera Biologics Inc FAQ

How is AbCellera Biologics Inc today?

AbCellera Biologics Inc today is trading in the red, and is down by -2.07% at 2.37.

How has AbCellera Biologics Inc performed historically?

AbCellera Biologics Inc is currently trading down -2.07% on an intraday basis. In the past week the stock rose 16.18%. stock has been up 1.28% in the past quarter and fell -37.30% in the past year. You can view this in the overview section.